NEXI-003

NexImmune Announces IND Clearance by the US FDA for NEXI-003 for the Treatment of HPV-Related Cancers
BioSpace
Thu, 07/14/22 - 08:01 pm
NexImmune
nanoparticles
solid tumors
NEXI-003
HPV-related cancer